Immix Biopharma
Price & Volume
Stats
See more52W Range | $1.26-$3.20 |
Market Cap | $73.1M |
Shares Short | 369,043 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.77 |
News
See moreYahoo Finance • 6 days ago
Immix Biopharma Announces 50% Enrollment Milestone Surpassed in its ongoing relapsed/refractory AL Amyloidosis Clinical Trial, NEXICART-2
Yahoo Finance • 13 days ago
Nancy T. Chang, Proven Biotechnology Leader, Joins Immix Biopharma Board of Directors
Yahoo Finance • 16 days ago
Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang
Yahoo Finance • 30 days ago
Immix Biopharma to Present at the Stifel 2025 Healthcare Conference
About
CEO | Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D. |
CFO | Mr. Gabriel Morris B.A. |
Address | 11400 West Olympic Boulevard, Los Angeles, CA, United States, 90064 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 18 |
